The JAK Inhibitor Pipeline Builds in Dermatology; Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.

Press/Media

Period	1 Apr 2023

Media coverage

Title	The JAK Inhibitor Pipeline Builds in Dermatology; Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Media name/outlet	Drug Topics (MJH)
Country/Territory	United States
Date	1/04/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=680Y-MNX1-JCXN-V3GN-00000-00
Persons	Nanette Silverberg